Browse > Article

The In-hospital Clinical Outcomes of Extracorporeal Life Support after Adult Cardiovascular Surgery  

Yie, Kil-Soo (Department of Thoracic and Cardiovascular Surgery, Kangwon National University Hospital, College of Medicine, Kangwon National University)
Na, Chan-Young (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Sejong Heart Institute)
Oh, Sam-Sae (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Sejong Heart Institute)
Kim, Jae-Hyun (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Sejong Heart Institute)
Ryu, Se-Min (Department of Thoracic and Cardiovascular Surgery, Kangwon National University Hospital, College of Medicine, Kangwon National University)
Park, Sung-Min (Department of Thoracic and Cardiovascular Surgery, Kangwon National University Hospital, College of Medicine, Kangwon National University)
Cho, Seong-Joon (Department of Thoracic and Cardiovascular Surgery, Kangwon National University Hospital, College of Medicine, Kangwon National University)
Publication Information
Journal of Chest Surgery / v.42, no.4, 2009 , pp. 464-472 More about this Journal
Abstract
Background: We analyzed the clinical results and the factors for survival of patients who underwent extracorporeal life support system after adult cardiovascular surgery. Material and Method: We retrospectively reviewed the medical record of 44 patients (1.6% of the total adult cardiovascular surgical cases) who underwent the use of a ventricular assisted device or extracorporeal membrane oxygenation from January 2002 to August 2008. There were 32 (72.7%) males and their mean age was 61.7$\pm$14.9(range: 20$\sim$73) years old. The mean duration of extracorporeal life support system was 5.3$\pm$3.0 (range: 1$\sim$12) days. Result: Of these 44 patients, 24 (54.5%) patients were successfully weaned from the extracorporeal device. Eighteen (40.9%) survivors were able to be discharged from the hospital. Complications were noted in 38 patients (86.4%). An emergency operation, no usage of a concomitant intraaortic balloon pump and major complications during use of the extra corporeal life support system such as bleeding, flow instability and renal failure were identified as significant risk factors for poor survival on univariated analysis. Owing to educational support and a continuous renal replacement therapy system, the clinical outcomes of these patients have improved since 2006. On multivariated analysis, renal failure and bleeding during extracorporeal life support were significant risk factors for poor survival. Conclusion: Although using. extracorporeal life support systems after adult cardiovascular surgery revealed acceptable clinical results, determining the optimal treatment strategy and further well designed larger studies are needed to improve the survival rate of patients who undergo extracorporeal life support after adult cardiovascular surgery.
Keywords
ECMO; VAD; PCPS; Cardiogenic shock; Cardiac surgery;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Osaki S, Edwards NM, Velez M, et al. Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience. Eur J Cardiothorac Surg 2008;34: 281-288   DOI   ScienceOn
2 Skoby M, Adrian K, Friberg LG, et al. Influence of hemofiltration on plasma cytokine levels and platelet activation during extracorporeal membrane oxygenation. Scand Cardiovasc J 2000;34:315-320   DOI   ScienceOn
3 Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004;77:151-157   DOI   ScienceOn
4 Bakhtiary F, Keller H, Dogan S, et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: Clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008;135:382-388   DOI   ScienceOn
5 Fuhrman BP, Hernan LJ, Rotta AT, Heard CMB, Rosenkranz ER. Pathophysiology of cardiac extracorporeal membrane oxygenation. Artif Organs 1999;23:966-969   DOI   ScienceOn
6 da Cruz EM, Behetti M, Kalangos A, et al. Mechanical support availability in pediatric cardiac surgery: Program size should not matter. Int J Cardiol 2008;129:282-284   DOI   ScienceOn
7 Sung K, Lee YT, Park PW, et al. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg 2006;82:651-656   DOI   ScienceOn
8 Barletta GM, Bunchman TE. Acute renal failure in children and infants. Curr Opin Crit Care 2004;10:499-504   DOI   ScienceOn
9 Magovern JA, Fonger JD, Wang DHJ, Kopilec D, Trumble DR, Smith DE. A femoral artery cannula that allows distal blood flow. J Thorac Cardiovasc Surg 2005;130:684-686   DOI   ScienceOn
10 Greason KL, Hemp JR, Maxwell JM, Fetter JE, Moreno- Cabral RJ. Prevention of distal limb ischemia during cardiopulmonary support via femoral cannulation. Ann Thorac Surg 1995;60:209-210   DOI   PUBMED   ScienceOn
11 Smythe MA, Koerber JM, Nowak SN, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmac 2002;36:7-11   DOI   ScienceOn
12 Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002; 73:538-45   DOI   ScienceOn
13 Baird CW, Zuakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007;83:912-920   DOI   ScienceOn
14 Conrad SA, Rycus PT. The ELSO Registry. In: Meurs KV, Lally KP, Peeks G, Zwischenberger JB. ECMO extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor: Extracorporeal Life Support Organization. 2005
15 De Waele JJ, Van Cauwenberghe S, Hoste E, Benoit D, Colardyn F. The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Int Care Med 2003;29:325-328   DOI   PUBMED
16 Chen YS, Lin JW, Yu HY, et al. Cardiopulmonary resuscitation with assisted extracorporeal lifesupport versus conventional cardiopulmonary resuscitation in adults with in- hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008;372:554-561   DOI   ScienceOn
17 Magovern GJ, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: the allegheny experience. Ann Thorac Surg 1999;68:655-661   DOI   ScienceOn
18 Golej J, Winter P, Schoffmann G, et al. Impact of extracorporeal membrane oxygenation modality on cytokine release during rescue from infant hypoxia. Shock 2003;20:110-115   DOI   ScienceOn
19 Kolla S, Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RH. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 1997;226: 554-566
20 Wu MY, Lin PJ, Tsai FC, Haung YK, Liu KS, Tsai FC. Impact of preexisting organ dysfunction on extracorporeal life support for non-postcardiotomy cardiopulmonary failure. Resuscitation 2008;79:54-60   DOI   ScienceOn